Rheumatoid arthritis (RA) is one of the most common autoimmune diseases. Genetic and
epidemiologic studies point to a relevant role of adaptive T-cell response interactions with …

It has been over 10 years since the topic of rheumatoid arthritis (RA) was considered in the
pages of Seminars in Immunopathology [1]. At the time, the focus was on the biologics …

Numerous novel therapies are in development for rheumatoid arthritis as a consequence of
tremendous progress in understanding pathogenic mechanisms and defining relevant …

Insights into rheumatoid arthritis (RA) have slowly evolved over the last century, but with
breathtaking speed over the last 2 decades. While only aspirin and parenteral gold were …

Rheumatoid arthritis (RA) is a multifactorial autoimmune disease characterized by chronic
inflammation and destruction of multiple small joints which may lead to systemic …

Rheumatoid arthritis (RA) is a chronic polyarthritis leading to joint destruction and
remarkable disability. Current therapies have various degrees of efficacy, but toxicity …

Rheumatoid arthritis (RA) is a systemic, inflammatory autoimmune disorder that presents as
a symmetric polyarthritis associated with swelling and pain in multiple joints, often initially …

Over the past several decades, immense progress has been made in the understanding of
the immune mechanisms and cytokine networks that contribute to the development and …

Enhanced understanding of the rheumatoid arthritis (RA) pathophysiology and the role of
cytokines has enabled the development of innovative biological agents in the last 10 years …

Rheumatoid arthritis is an autoimmune disease characterized by the production of two
known antibodies–rheumatoid factor and anti-citrullinated peptide antibody (ACPA)–against …